Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.58 |
| ▸ | DRD2 | P14416 | 2/20 | 0.55 |
| ▸ | DRD1 | P21728 | 1/20 | 0.55 |
| ▸ | DRD4 | P21917 | 1/20 | 0.55 |
| ▸ | DRD5 | P21918 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nafadotride SCHEMBL31555135 | 1.00 | DRD3 (1.00) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8525891 | 0.97 | DRD3 (0.95) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8527772 | 0.92 | KDM4E (0.85) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8528795 | 0.92 | DRD3 (0.85) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8526940 | 0.88 | DRD3 (0.79) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8525946 | 0.87 | KDM4E (0.77) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8528369 | 0.86 | DRD3 (0.76) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| Hydrochloric Acid SCHEMBL9091591 | 0.86 | KDM4E (0.75) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8527263 | 0.81 | KDM4E (0.69) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL8526450 | 0.81 | DRD3 (0.68) | DRD3KDM4EALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107412-A1 | SARCOSPAN MODULATION AND METHODS OF MEAT AND TISSUE CULTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| US-20250319074-A1 | TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME | UNIV EAST CAROLINA (US) | 2025-10-16 | — | — | US | claimed |
| EP-3801510-B1 | COMPOUNDS INCREASING THE EXPRESSION OF SARCOSPAN FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHY | UNIV CALIFORNIA (US) | 2025-04-23 | — | — | EP | claimed |
| US-12220404-B2 | Treatment and management of augmentation in restless legs syndrome | EAST CAROLINA UNIVERSITY (US) | 2025-02-11 | — | — | US | claimed |
| US-12109204-B2 | Methods for treating muscular dystrophies | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-08 | — | — | US | claimed |
| EP-3313407-B1 | TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME | UNIV EAST CAROLINA (US) | 2023-07-19 | — | — | EP | claimed |
| EP-4178948-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | Universidade de Santiago de Compostela (ES) | 2023-05-17 | — | — | EP | claimed |
| WO-2023049482-A1 | METHODS OF TREATING RESTRICTIVE EATING DISORDERS | ARVID THERAPEUTICS (US) | 2023-03-30 | — | — | WO | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| WO-2022023496-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-02-03 | — | — | WO | claimed |
| WO-2006052626-A2 | DOPAMINE 3 RECEPTOR AGONIST AND ANTAGONIST TREATMENT OF GASTROINTESTINAL MOTILITY DISORDERS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| WO-2005105839-A2 | ESSENTIAL TREMOR DIAGNOSTIC AND TREATMENT | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2005-11-10 | — | — | WO | claimed |
| EP-1591455-A1 | Essential tremor diagnostic and treatment | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2005-11-02 | — | — | EP | claimed |
| US-20040176467-A1 | Method of preventing or reducing the occurrence of symptoms of psychosis | VETERANS AFFAIRS, UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE | 2004-09-09 | — | — | US | claimed |
| WO-2003013507-A1 | METHOD OF PREVENTING OR REDUCING THE OCCURRENCE OF SYMPTOMS OF PSYCHOSIS | THE UNITED STATES OF AMERICA AS REPRESENTED BY DEPARTMENT OF VETERANS AFFAIRS (US) | 2003-02-20 | — | — | WO | claimed |
| EP-0539281-B1 | Naphthamides, process for their preparation and their application in the therapeutical field | INST NAT SANTE RECH MED (FR) | 1998-12-30 | — | — | EP | claimed |
| EP-0539281-A1 | New naphthamides, process for their preparation and their application in the therapeutical field | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1993-04-28 | — | — | EP | claimed |